Publications by authors named "Flavia D Xavier"

Claim this Profile
A
A comparative analysis between real-time polymerase chain reaction and next-generation sequencing for the simultaneous detection of key fusions in acute myeloid leukaemia.
Andressa Folha Vieira, Fabian Andres Hurtado Erazo, Amanda Minafra Reys Lamas, Claudia Ferreira de Sousa, Gabryelle Louisse Bezerra Souza, Flávia Dias Xavier

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.
Flávia Dias Xavier, Danielle Leão Cordeiro de Farias, Abrahão Elias Hallack Neto, Glaciano Nogueira Ribeiro, Marco Aurelio Salvino de Araujo, Thiago Xavier Carneiro

Oncotarget· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention.
Rodrigo B Aires, Alexandre A de S M Soares, Ana Paula M Gomides, André M Nicola, Andréa Teixeira-Carvalho, Flávia D Xavier

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migratory pulmonary infiltrates in a patient with COVID-19 and lymphoma.
Alfredo N C Santana, Felipe X Melo, Flavia D Xavier, Veronica M Amado

J Bras Pneumol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak.
Flávia Dias Xavier, Fernando Sergio Blumm Ferreira, Rodrigo Martins Abreu

Oncotarget· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative, pro-inflammatory, and angiogenesis regulator gene expression profile defines prognosis in different histopathological subtypes of nodal peripheral T-cell lymphoma.
Luís Alberto de Pádua Covas Lage, Débora Levy, Flávia Dias Xavier, Diego Cândido Reis, Renata de Oliveira Costa

Oncotarget· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?
Flávia Dias Xavier, Paulo Marcelo Gehm Hoff, Maria Ignez Braghiroli, Ana Carolina Carvalho Rocha Paterlini, Karla Teixeira Souza

J Glob Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-to-treatment of diffuse large B-cell lymphoma in São Paulo.
Flávia Dias Xavier, Debora Levy, Juliana Pereira

Clinics (Sao Paulo)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease progression after R-CHOP treatment associated with the loss of CD20 antigen expression.
Marcelo Bellesso, Flavia Dias Xavier, Renata Oliveira Costa, Juliana Pereira, Sheila Aparecida Coelho Siqueira

Rev Bras Hematol Hemoter· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis